J Biol Chem, Vol. 274, Issue 28, 20017-20026, July 9, 1999
Requirement for Reactive Oxygen Species in Serum-induced and
Platelet-derived Growth Factor-induced Growth of Airway Smooth
Muscle*
Sukhdev S.
Brar
,
Thomas P.
Kennedy
**,
A. Richard
Whorton§,
Thomas M.
Murphy¶,
Pasquale
Chitano¶, and
John R.
Hoidal
From the
Department of Internal Medicine, Carolinas
Medical Center, Charlotte, North Carolina 28232, the Departments
of § Pharmacology and ¶ Pediatrics, Duke University
Medical Center, Durham, North Carolina 27710, and
Division of Respiratory, Critical Care, and Occupational
(Pulmonary) Medicine, Department of Internal Medicine, University of
Utah, Salt Lake City, Utah 84132
 |
ABSTRACT |
Reactive oxygen species have been recently
identified as important mediators of mitogenic signaling in a number of
cell types. We therefore explored their role in mediating mitogenesis
of airway smooth muscle. The antioxidants catalase,
N-acetylcysteine, and probucol significantly reduced
proliferation in primary cultures of rat tracheal smooth muscle
stimulated with fetal bovine serum or platelet-derived growth factor,
without affecting cell viability or inducing apoptosis.
N-Acetylcysteine also significantly reduced serum-stimulated elevation of c-Fos but did not prevent the normal mitogen-induced increase in c-fos mRNA. Fractionation
of ribosomes by sucrose density centrifugation and subsequent dot-blot
Northern analysis revealed that antioxidants reduced incorporation of
c-fos mRNA into the heaviest polyribosomes, suggesting
redox regulation of c-fos mRNA translation. Serum
treatment of monolayers produced a small but reproducibly significant
rise in superoxide dismutase-inhibitable reduction of ferricytochrome
c by myocyte monolayers. Serum-induced ferricytochrome
c reduction, cellular proliferation, and c-Fos elevation were decreased by the flavoprotein-dependent
enzyme inhibitor dipheyleneiodonium. Growth responses to fetal bovine serum and superoxide dismutase-inhibitable reduction of ferricytochrome c were not different between cultured tracheal myocytes
from wild-type versus gp91 phagocyte oxidase null mice.
These results suggest that mitogen stimulation of airway smooth muscle
induces signal transduction of cell proliferation that is in part
dependent on generation of partially reduced oxygen species, generated
by an NADH or NADPH oxidoreductase that is different from the oxidase in phagocytic cells.
 |
INTRODUCTION |
Reactive oxygen species have long been recognized as important
mediators of inflammation, injury, and cell death. Now, evidence is
accumulating that small amounts of reactive oxygen species generated in
select cell compartments can trigger signal transduction leading to
gene expression (1-6). Oxidant signaling might be especially important
in the asthmatic airway, where smooth muscle proliferation in chronic
severe asthma contributes to development of fixed airways obstruction.
H2O2 treatment of tracheal myocytes successively stimulates protein kinase C, Raf-1, and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 pathways,
leading to activation of extracellular signal-regulated kinases,
serine/threonine kinases of the mitogen-activated protein kinase
superfamily important in transduction of mitogenic signals to the
nucleus (7, 8). This has important implications for the pathogenesis of
remodeling in the asthmatic airway, where myocytes are exposed to
reactive oxygen species from activated eosinophils, neutrophils,
monocytes, and macrophages. However, airway smooth muscle is also
constantly stimulated by mitogens, including platelet-derived growth
factor, endothelin, histamine, tumor necrosis factor-
, and even
serum as a consequence of submucosal edema and increased submucosal
vascular permeability in asthma (10-13). Recently, growth factor
treatment of fat cells (14, 15), renal mesangial cells (2, 5, 9),
endothelium (3), and fibroblasts (4, 6) has been shown to stimulate
production of superoxide anion (O
2) and
H2O2, which are important for mitogenic signaling. One proposed source of these species is a cytochrome b558- and flavoprotein-dependent
membrane NADH or NADPH oxidoreductase similar to that found in
phagocytes (2, 4, 9). However, the exact structural nature of this
oxidase and its relation to growth factor-stimulated proliferative
responses are not completely defined. We therefore investigated whether
mitogen-stimulated tracheal myocytes also generate reactive
oxygen species that are important for signaling cellular proliferation.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Male adult Sprague-Dawley rats were purchased
from Charles River (Raleigh, NC). Transgenic mice lacking the gene for
the gp91 component of phagocyte oxidase (gp91phox) were a gift
from Dr. Mary Dinauer (Indiana University, Indianapolis, IN) (16).
Protease inhibitors and guanidine thiocyanate were obtained from Roche
Molecular Biochemicals. Diphenyleneiodonium chloride was from Aldrich.
Dulbecco's modified Eagle's medium (DMEM),1 Hanks' balanced
salt solution (HBSS), HEPES, antibiotic-antimycotic (10,000 units of
penicillin, 10,000 µg of streptomycin, and 25 µg of amphotericin
B/ml) and trypsin-EDTA solution were purchased from Life Technologies,
Inc. Fetal bovine serum (FBS) was purchased from HyClone (Logan, UT).
Recombinant human platelet-derived growth factor-AB (PDGF-AB) was
obtained from R&D Systems (Minneapolis, MN). Antibodies for
c-Fos (antibody-2, rabbit polyclonal antibody) and A431 cell
lysate standard were from Calbiochem (San Diego, CA). Antibodies to
Fos-B (102-G, goat polyclonal) and peroxidase-labeled anti-goat IgG
were from Santa Cruz Biotechnology (Santa Cruz, CA). Peroxidase-labeled
sheep polyclonal anti-mouse and donkey polyclonal anti-rabbit IgG were
from Amersham Pharmacia Biotech. M-MLV reverse transcriptase was from
Promega (Madison, WI). Catalase (bovine liver), cytochrome c
(horse heart), N-acetylcysteine, probucol, copper-zinc
superoxide dismutase (bovine erythrocyte), horseradish peroxidase (type
II), antibody for
-smooth muscle actin and all other materials were
purchased from Sigma, unless specified.
Culture of Airway Smooth Muscle--
Rat or mouse tracheal
smooth muscle was cultured as previously reported (17, 18). Briefly,
adult male Sprague-Dawley rats and wild-type or gp91phox null
mice were euthanized, and the posterior tracheal membrane was digested
twice for 30 min at 37 °C in HBSS containing 0.2% type IV
collagenase and 0.05% type IV elastase. Enzyme digests were
centrifuged at 500 × g, and the pellet was resuspended
and cultured in DMEM supplemented with 10% FBS, nonessential amino acids, penicillin (100 units/ml), streptomycin (100 µg/ml), and amphotericin (250 ng/ml) in a humidified atmosphere of 5%
CO2/95% air at 37 °C. Upon reaching confluence, cells
were passed with 0.25% trypsin-0.002% EDTA. Immunostaining was
performed using a polyclonal antibody against
-smooth muscle actin
(Sigma) and visualized using an avidin-biotin-immunoperoxidase
technique. Smooth muscle cultures demonstrated the typical "hill and
valley" appearance under phase-contrast microscopy and stained avidly for
-smooth muscle actin. Preliminary studies demonstrated that culture of cells in the presence of 10% FBS resulted in a linear growth phase up to 120 h. Cultures from passages 2-9 were used for experiments.
Measurement of Cultured Airway Smooth Muscle
Proliferation--
Proliferation of cultured airway smooth muscle was
quantitated using a previously reported colorimetric method based upon metabolic reduction of the soluble yellow tetrazolium dye
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to
its insoluble purple formazan by the action of mitochondrial succinyl
dehydrogenase (18). This assay empirically distinguishes between dead
and living cells. For proliferation studies, cells were seeded into
24-well uncoated plastic plates (Costar) at 15,000-50,000 cells per
well and cultured with DMEM and mitogens. After 24-96 h, medium was
removed, cells were washed twice with 1 ml of sterile Dulbecco's
modified phosphate-buffered saline (DPBS) without Ca2+ or
Mg2+, the medium was replaced with 1 ml/well fresh DMEM
containing 100 µg/ml MTT and 0.5% FBS, and plates were incubated for
an additional 1 h. MTT-containing medium was removed, 0.5 ml of
dimethyl sulfoxide (Me2SO) was added to each well, and the
absorbance of the solubilized purple formazan dye was measured at 540 nm. A total of 4-6 wells was studied under each treatment condition.
Preliminary studies were performed with 50-200 µg/ml MTT incubated
for 15 min to 3 h to determine the optimum concentration and
incubation time at which the rate of conversion was linear and
proportional to the number of cells present. The absorbance of the MTT
formazan reduction product (A540) correlated
with cell numbers counted by hemocytometer with an
R2 = 0.99. In some experiments, the MTT assay
and responses to mitogens and inhibitors were also confirmed by
performing cell counts on 10 random fields/well of Giemsa-modified
Wright's stained monolayers viewed at a magnification of × 40 using a
0.01-cm2 ocular grid.
Cell Culture Treatments--
Cell proliferation was studied in
cultures stimulated with 0.5-10% FBS or 0-75 ng/ml PDGF-AB. To
explore the role of oxidants in signaling mitogenesis, we tested the
effects on cell proliferation of supplementing media with the
O
2 scavenger superoxide dismutase (SOD) (300-3000 units/ml)
the H2O2 scavenger catalase (300-3000 units/ml), the sulfhydryl donor and hydroxyl radical (·OH) scavenger N-acetylcysteine (NAC) (10 mM), the antioxidant
lipid lowering agent probucol (10
6 to 10
3
M) (19), the xanthine oxidase inhibitor allopurinol (1 mM), the nitric oxide synthase inhibitor
N
-nitro-L-arginine (100 µM), and the NADH/NADPH oxidoreductase flavoprotein inhibitor
diphenyleneiodonium (DPI) (5-25 µM) (20).
To study the effect of antioxidants or DPI on early response genes
important for cellular proliferation, confluent rat tracheal myocytes
in 6-well plates were growth-arrested for 24 h in serum-free DMEM
and stimulated with 10% FBS and DMEM, in the presence or absence of
3000 units/ml catalase or 20 mM NAC at the time of stimulation. In some experiments, growth-arrested monolayers were also
preincubated with catalase or NAC 2 h prior to stimulation. After
30, 60, or 90 min, cells were lysed and c-fos mRNA was
measured by RT-PCR, Northern blotting, and ribonuclease protection
assay, as described below. To study whether levels of c-Fos or Fos-B were affected, confluent rat myocyte monolayers on 6-well plates were
growth-arrested for 48 h in 0.5% FBS and DMEM. Cells were then
pretreated with catalase (3000 units/ml) or NAC (20 mM) for 2 h or DPI (25 µM) for 30 min and stimulated with
10% FBS and DMEM for 15, 30, or 60 min, in the presence of additional
scavengers or DPI added at the time of stimulation. Cells were then
lysed, and c-Fos and Fos-B were assayed by immunoblotting as described below. To determine whether antioxidants influenced the rate of c-Fos
elimination, confluent rat myocytes grown in 25-cm2 Petri
dishes were growth-arrested for 24 h in 0.5% FBS and DMEM and
stimulated with 10% FBS and DMEM. After 60 min, stimulated cells were
treated with 20 mM NAC or DPBS vehicle, and cycloheximide (25 µg/ml) was added to media to block further message translation. Cells were then harvested 1,2,4 and 6 h later for immunoblot assay of c-Fos. Finally, to study potential regulation of c-Fos production at
the ribosomal level, rat tracheal myocytes were grown to confluence in
T-80 flasks, growth-arrested in DMEM for 72 h, preincubated with
3000 units/ml catalase or 20 mM NAC for 2 h, and
stimulated for 30 min with 10% FBS in the presence or absence of
antioxidants. Cells were then harvested, polysomes were fractionated by
sucrose gradient centrifugation, and purified mRNA from each
fraction was subjected to dot-blot Northern assay for c-fos
as described below.
Measurement of Superoxide Anion (O
2)
Generation--
O
2 generation by FBS stimulated airway smooth
muscle cells was measured by the technique of SOD-inhibitable reduction
of ferricytochrome c (21), employing a modification allowing
absorbance reading with an automatic enzyme immunoassay reader (22).
Confluent cells grown on 24-well plates were growth-arrested for
72 h in serum-free DMEM, washed with DPBS, and incubated at
37 °C with 160 µM ferricytochrome c in
total volume of 400 µl of HBSS (phenol red-free) with and without
10% FBS or copper-zinc SOD (300 units/ml). The absorbance of each
well, blanked to replicate wells incubated with ferricytochrome
c and SOD without FBS, was measured at 550 nm initially and
again after 60 min of serum stimulation using an ELx800UV automated
microplate reader (Biotek Instruments, Highland Park, VT). Monolayers
were then washed with DPBS, and cell protein was measured using the BCA
protein assay (Pierce). O
2 generation, normalized to cell
protein, was computed from the Beer-Lambert relationship (23) as the
quotient of SOD-inhibitable increase absorbance over time divided by
the difference between the molar extinction coefficients for
ferricytochrome c and ferrocytochrome c
(
EM = 2.1 × 104 M
1
cm
1) (21) and a measured light path length of 1 mm. In
some experiments, DPI (10 µM) was added to medium 30 min
before and again at the time of serum stimulation to determine the
magnitude of ferricytochrome c reduction that might be
attributable to flavoprotein containing NADH or NADPH oxidoreductases.
Measurement of Cytotoxicity and Apoptosis--
To assess for
cytotoxicity, DPI (5-50 µm), catalase (3000 units/ml) or NAC (20 mM) was added to wells of airway smooth muscle cells grown
to confluence on 24 well plates and growth-arrested for 24 h in
0.5% FBS and DMEM. After 24 h, lactate dehydrogenase activity in
microcentrifuged supernatant was measured using a commercially
available assay (DG-1340K from Sigma). Cell death was assessed by
trypan blue dye exclusion.
To confirm that antioxidants were suppressing growth mechanisms rather
than inducing apoptosis, cells grown to confluence on 35-mm Petri
dishes or on glass slides were treated with 3000 units/ml catalase or
20 mM NAC for 24 h. Apoptosis was studied by visually
assessing endonuclease dependent DNA fragmentation on ethidium
bromide-stained agarose gels, as previously reported (18). Briefly,
confluent cultures treated with drug for 24 h were washed twice
with DPBS, scraped on ice into 1.5-ml microcentrifuge tubes and
centrifuged at 250 × g for 5 min at 4 °C. The cell
pellet was gently resuspended in 30 µl of DPBS and lysed by addition of 30 µl of lysis buffer (80 mM EDTA, 1.6% (w/v) sodium
lauryl sarcosinate, and 5 mg/ml proteinase K in 200 mM
Tris-HCl, pH 8.0). Lysate was incubated at 50 °C for 24 h.
RNase (0.2 mg/ml) was added, and the lysate was incubated for another
2 h at 37 °C. DNA was extracted by the phenol-chloroform method
(24), and bands were separated along with a DNA ladder standard on a
1% agarose gel at 60 V for 1 h, intercalated with eithidium
bromide, and visualized and photographed under UV light. Apoptosis was also studied by terminal deoxynucleotidyl
transferase-dependent 3'-OH fluorescein end-labeling of DNA
fragments, using a Fluorescein-FragELTM DNA fragmentation
detection kit (Oncogene Research Products, Cambridge, MA). Treatment of
cells with 100 µM pyrrolidinedithiocarbamate was used as
a positive control (25).
Immunoblot Assay for Fos Proteins--
Fos gene family products
were quantitated as described previously (18). Cells were placed on
ice, washed twice with cold DPBS, scraped into 0.5 ml of boiling buffer
(10% (v/v) glycerol and 2% (w/v) SDS in 83 mM Tris, pH
6.8) and sheared by four passages through a pipette. Aliquots were
removed for protein determination, as described previously. After 10%
-mercaptoethanol and 0.05% bromphenol blue were added, lysates were
boiled for 5 min and stored at
80 °C until immunoblotting was
performed. Proteins in defrosted samples were separated by
SDS-polyacrylamide gel electrophoresis on 12% polyacrylamide gels (15 µg of protein/lane) and electrotransferred to 0.45 µm Hybond ECL
nitrocellulose membranes (Amersham Pharmacia Biotech) using the wet
transblot method in transfer buffer (0.025 M Tris, 0.192 M glycine, 2.6 mM SDS, and 20% (v/v) methanol;
pH 8.8) at 100 volts for 1 h. Blots were blocked overnight at
4 °C with blocking buffer (PBS with 0.1% Tween 20) containing 5%
fat-free milk powder (Carnation, Glendale, CA). After rinsing five
times for 5 min each in PBS containing 0.1% Tween 20, blots were
incubated for 1 h at room temperature with 2.0 µg/ml of c-Fos
polyclonal antibody. After rinsing again as above, blots were incubated
for 1 h at room temperature with anti-rabbit IgG/horseradish
peroxidase antibody diluted 1:2000 in blocking buffer as the secondary
antibody for c-Fos. Immunoblots were rinsed again as above and detected
via an enhanced chemiluminescence method (ECL Western blotting
detection system, Amersham Pharmacia Biotech). Autoradiographic film
(X-OMAT AR, Eastman Kodak) was exposed to immunoblots for 10, 30, or
60 s to obtain satisfactory images that were quantitated by laser
densitometry using Kodak 1D image analysis software (Kodak). Fos B was
assayed similarly using polyclonal goat anti-Fos B primary and
anti-goat IgG/horseradish peroxidase secondary antibodies.
Reverse Transcription-Polymerase Chain
Reaction--
Semi-quantitative RT-PCR was performed by modification
of procedures previously described (18, 26). Cell monolayers were washed twice with DPBS and lysed with 4 M guanidine
thiocyanate, 25 mM sodium citrate, and 0.5% Sarkosyl.
After scraping, lysates were sheared with four passes through a
pipette. RNA was extracted using the phenol-chloroform method (24) and
quantitated spectrophotometrically at 260 and 280 nm. RNA (2 µg) was
reverse transcribed using 200 units of M-MLV reverse transcriptase
(Promega) in a reaction mixture containing 1 mM dATP, dCTP,
dGTP, and dTTP; 40 units of RNase inhibitor; 25 µM random
hexamers; 5 mM MgCl2; 500 mM KCl;
and 100 mM Tris-HCl (pH 8.3), in a total volume of 20 µl.
The reaction was performed at 42 °C for 60 min followed by heat
inactivation for 5 min at 95 °C. The resultant cDNA was PCR
amplified for 30 and 35 cycles for GAPDH and c-fos,
respectively, using rat gene-specific sense and antisense primers (18)
based on sequences published in GenBankTM: GAPDH, 5'
ACCACCATGGAGAAGGCTGG 3' and 5' CTCAGTGTAGCCCAGGATGC 3' (528 bp
product); c-fos, 5' ACTGGATAGAGCCGGCGGAG 3' and 5' GGCTGGTGGAGATGGCTGTC 3' (331 bp product), respectively. The specificity of primers for rat c-fos was confirmed by Southern blotting
performed using a sequence internal to the chosen primers. PCR was
carried out on a Perkin-Elmer DNA thermal cycler 480. Amplification for GAPDH was carried out by 30 cycles at 94 °C for 1 min, 60 °C for 2 min, and 72 °C for 1 min, followed by an extension step at
72 °C for 10 min. PCR conditions for c-fos were 35 cycles
at 94 °C for 1 min, 56 °C for 2 min, and 72 °C for 1 min
followed by an extension step at 72 °C for 10 min. PCR-amplified DNA
was separated on 1.6% agarose gel, stained with ethidium bromide, and
visualized and photographed under ultraviolet light. The resulting
Polaroid negative was quantitated by laser densitometry. The intensity of the GAPDH cDNA bands (a housekeeping gene unaffected by
stimulation with FBS) for each sample was then used to normalize for
loading differences in c-fos band intensities.
Northern Blotting--
GAPDH and c-fos antisense
probes were generated from rat pTRI-GAPDH and mouse
p-TRI-c-fos/exon 4 linearized plasmids (Ambion, Austin, TX)
using T7 RNA polymerase, producing fragments of 383 and 299 bases,
respectively. The probe generated for c-fos had >95%
homology with the sequence for rat c-fos. Probes were
labeled for 1 h at 37 °C with 32P-UTP (Amersham
Pharmacia Biotech) at a final concentration of 12.5 µM,
purified on SELECT-D(RF) Spin Chromatography columns (5 Prime
3 Prime, Inc., Boulder, CO) and quantitated on a Beckman LS 60001C
scintillation counter. Northern blots were performed with a kit from
Ambion according to the manufacturer's instructions. Briefly, RNA (15 µg) was electrophoresed on a 1.2% formaldehyde-agarose gel and
transferred overnight to a nylon membrane. After UV cross-linkage, membranes were prehybridized at 65 °C for 2 h and hybridized at 65 °C for 14 h with 106 cpm/ml of
32P-labeled c-fos cRNA. Membranes were washed
twice for 5 min at room temperature with low stringency wash solution
(Ambion), washed twice for 15 min at 65 °C with high stringency
solution (Ambion), and exposed overnight to Kodak XAR-5 film in an
image intensifying cassette at
80 °C. Bands were quantitated by
laser densitometry. Equivalent loading of total RNA was verified by
stripping c-fos probe from the membrane by boiling in 0.1%
SDS in diethyl pyrocarbonate-treated water and hybridizing with
106 cpm/ml of 32P-labeled cRNA probe for GAPDH
generated similarly from rat pTRI-GAPDH (Ambion).
Ribonuclease Protection Assay--
Ribonuclease protection
assays were performed according to the manufacturer's instructions
using a kit from Ambion. Briefly, RNA (15 µg) was hybridized at
50 °C for 16 h with 6 × 104 cpm/tube GAPDH
and 3 × 105 cpm/tube c-fos antisense
probes. The unprotected RNA was digested at 37 °C for 30 min with
RNase T1 in RNase digestion buffer. The reaction was stopped by
addition of 300 µl of RNase inactivation/precipitation mixture. RNA
samples were resuspended in 15 µl of formaldehyde loading buffer,
heat denatured for 4 min at 95 °C and electrophoresed on 5%
acrylamide/8 M urea denaturing gels. Gels were transferred to filter paper, imaged by autoradiography as described above, and
quantitated by laser densitometry.
Sucrose Gradient Fractionation of Polyribosomes--
Cells were
trypsinized, harvested by centrifugation, and washed twice with
ice-cold DPBS containing 50 µg/ml cycloheximide. Cells were then
lysed by incubation for 10 min in 1 ml of ice-cold lysis buffer (0.25 M sucrose, 250 mM KCl, 5 mM
MgCl2, 1 mM dithiothreitol, 100 µg/ml
cycloheximide, 0.5% (v/v) Triton X-100, and 0.2 mg/ml heparin (as a
ribonuclease inhibitor) in 20 mM HEPES, pH 7.5). The lysate
was then microcentrifuged for 10 min at 4 °C and 14,000 rpm. Linear
15-50% (w/v) sucrose gradients (12.5 ml) were prepared by a
two-chamber gradient maker (Amersham Pharmacia Biotech) and pumped into
centrifuge tubes (Beckman Ultra-Clear 14 × 80 mm). The
non-sucrose component of the gradient solution was the same as the
lysis buffer, except that the concentration of KCl and heparin were 500 mM and 0.5 mg/ml, respectively. Aliquots (800 µl) of
microcentrifuged supernatant, representing material from approximately
4 × 106 cells, were layered onto the gradient and
centrifuged at 40,000 rpm for 110 min at 4 °C in a Beckman
Ultracentrifuge using a 40Ti rotor. The bottom of the tube was
punctured by a needle and tubing connected to a peristaltic pump, and
gradient fractions of 600 µl were collected into 1.5-ml
microcentrifuge tubes containing 3 µl of 20% (w/v) SDS and 50 µl
of 4 M sodium acetate, pH 5.0. RNA in each fraction was
extracted by the phenol chloroform method (24) and dot-blotted onto
nylon membrane as described previously (27). Membranes were then
subjected to Northern blotting for c-fos as described above.
Statistical Analysis--
Data are expresssed as mean
values ± S.E. The minimum number of replicates for all
measurements was four, unless otherwise indicated. Differences between
multiple groups were compared using one-way or two-way analysis of
variance. The post hoc test used was the Newman-Keuls
multiple comparison test. Two-tailed tests of significance were
employed. When data was not found by the Shapiro-Wilkes test to be
normally distributed, the Wilcoxon rank sum test was employed.
Significance was assumed at p < 0.05.
 |
RESULTS |
FBS and PDGF promoted rat airway smooth muscle cell growth in a
dose-dependent manner, as previously reported (18). PDGF was only about half as potent as FBS. SOD slightly enhanced cell growth
in cultures stimulated with PDGF, but catalase at 300 and 3000 units/ml
and NAC at concentrations of 10 mM and greater
significantly inhibited airway smooth muscle proliferation in response
to FBS or PDGF (Fig. 1). Antioxidant
treatment of confluent rat tracheal myocyte monolayers did not induce
LDH release, cause uptake of trypan blue or produce DNA fragmentation,
as studied by ethidium bromide stained agarose gels or by 3'-OH
fluorescent end-labeling of DNA fragments (data not shown). This
suggests that reactive oxygen species and and cellular redox status are
important for mitogen-stimulated signal transduction in these cells.
Treatment with NAC also caused a significant decrease in FBS-stimulated production of the early response gene product c-Fos (Fig.
2). Fos-B was expressed at identical low
levels in both growth-arrested and serum-stimulated cultures and was
not influenced by antioxidants (data not shown). Antioxidants did not
prevent serum stimulation of c-fos mRNA (Fig.
3), which we studied by three different
methodologies. Semiquantitative PCR, Northern blotting, and
ribonuclease protection assays all consistently confirmed that
antioxidants did not block the normal early response increase of
myocyte c-fos mRNA from mitogenic stimulation. This
suggests that reactive oxygen species and alterations in redox status
effected in response to mitogens may also regulate early response genes
at a posttranscriptional level. To probe whether antioxidants might
affect rates of proteolytic destruction, we stimulated c-Fos expression
for 60 min with 10% FBS and then inhibited further translation of
mRNA by addition of cycloheximide (25 µg/ml) to cultures. Fig.
4A shows that the rate of
elimination of c-Fos was not changed substantially by treatment of cells with NAC, raising the possibility that antioxidants might regulate levels of protein by influencing the degree of message
translation. This was confirmed by Northern dot-blots of
c-fos mRNA in polyribosomes size fractionated by linear
sucrose gradient centrifugation. Fig. 4B demonstrates that
compared with stimulation with FBS alone (rows A and
B), pretreatment with 3000 units/ml catalase (rows
C and D) or 20 mM NAC (rows E
and F) eliminates detection of c-fos mRNA in
the heaviest polyribosomal fractions that actively translate mRNA
into protein.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Antioxidants inhibit mitogen-stimulated rat
airway smooth muscle proliferation. Cells were cultured with
either 10% FBS or 75 ng/ml PDGF + 0.5% FBS and PBS vehicle.
Proliferation of cultured airway smooth muscle was quantitated by
assessing cell number-dependent reduction of the soluble
yellow tetrazolium dye MTT to its insoluble formazan, measured as the
absorbance at 540 nm (A540) (17, 18). Effects of
copper-zinc SOD (A), catalase (B), and NAC
(C) are shown on FBS-stimulated growth of airway smooth
muscle cells. Effects of SOD, catalase, and N-acetylcysteine
(D) are shown on PDGF-stimulated growth of airway smooth
muscle cells. A and B, , 0.5% FBS; , 10%
FBS; , 10% FBS + 300 units/ml SOD; , 10% FBS + 3000 units/ml
SOD. C, , 0.5% FBS; , 10% FBS; , 10% FBS + 10 mM NAC; , 10% FBS + 20 mM NAC.
D, , 0.5% FBS; , 75 ng/ml PDGF; , PDGF + 3000 units/ml SOD; , PDGF + 3000 units/ml catalase; , PDGF + 10 mM NAC. Each column represents the mean MTT
formazan absorbance in 6-8 experiments produced by 50,000 cells/well
cultured for 48 h. Similar results were noted in experiments at 24 and 72 h. *, p < 0.001 compared with 0.5% FBS;
+, p < 0.001 compared with 10% FBS or 75 ng/ml PDGF + 0.5% FBS.
|
|

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
Antioxidants reduce mitogen-induced
expression of c-Fos in rat airway smooth muscle. Growth-arrested
cells were pretreated with catalase (3000 units/ml) or NAC (20 mM) for 2 h with antioxidants, and antioxidants were
added to medium again when cells were stimulated with 10% FBS. After
15, 30, or 60 min, cells were lysed, and protein extracts were
subjected to SDS-polyacrylamide gel electrophoresis following by
Western blotting using a specific anti-c-Fos antibody. Bands were
detected using enhanced chemiluminescence reagents. A,
catalase modestly reduced and N-acetylcysteine significantly
reduced FBS stimulation of c-Fos levels in airway smooth muscle cells.
Protein gel of a typical experiment after 60 min of stimulation:
lane 1, unstimulated 0.5% FBS control; lane 2, 10% FBS after 60 min; lane 3, 10% FBS + 3000 units/ml
catalase; lane 4, 10% FBS + 20 mM NAC.
B, summary of three experiments after 60 min of stimulation.
Raw absorbances were corrected by subtracting respective 0.5% FBS in
DMEM control values and expressed as optical density relative to
control. , 10% FBS; , FBS + 3000 units/ml catalase; , FBS + 20 mM NAC. *, p < 0.05 compared with 10%
FBS.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Serum-induced transcription of the early
response gene c-fos is not reduced in rat airway
smooth muscle by antioxidants. A, catalase (3000 units/ml) or NAC
(20 mM) did not prevent the normal increase in
c-fos mRNA as measured by semiquantitative RT-PCR at 30, 60, and 90 min after stimulation with 10% FBS. Growth-arrested cells
were pretreated for 2 h with antioxidants, and antioxidants were
added to medium again when cells were stimulated with 10% FBS. PCR
gels for c-fos and GAPDH, a housekeeping gene unaffected by
serum stimulation, are shown for a typical experiment: lanes 1, 5, and 9, 0.5% FBS after 30, 60, and 90 min,
respectively; lanes 2,6, and 10, 10% FBS after
30, 60, and 90 min; lanes 3, 7, and 11, 10% FBS + 3000 units/ml catalase after 30, 60, and 90 min; lanes
4,8, and 12, 10% FBS + 20 mM NAC after 30, 60, and 90 min; lane M, molecular weight markers.
B, summary of three experiments after 60 min of stimulation.
Expression of c-fos mRNA is normalized to GAPDH. ,
0.5% FBS; , 10% FBS; , FBS + 3000 units/ml catalase; , FBS + 20 mM NAC. *, p < 0.05 compared with 0.5%
FBS. C, results with RT-PCR were confirmed by Northern
blots. Antioxidants did not prevent and may have even enhanced (NAC,
lane 4) serum stimulation of c-fos mRNA. The
figure shown is representative of three experiments: lane 1, 10% FBS after 30 min; lane 2, 0.5% FBS after 30 min;
lanes 3, 5, and 7, 10% FBS + 3000 units/ml
catalase after 30, 60, and 90 min; lanes 4, 6, and
8, 10% FBS + 20 mM NAC after 30, 60, and 90 min. D, results with RT-PCR were also confirmed by
ribonuclease protection assays. Antioxidants did not prevent serum
stimulation of c-fos mRNA. The figure shown is
representative of three experiments: lane 1, GAPDH antisense
probe; lane 2, GAPDH probe + T1 RNase; lane 3, c-fos antisense probe; lane 4, c-fos
probe + T1 RNase; lane 5, 10% FBS after 30 min; lane
6, 0.5% FBS after 30 min; lanes 7, 9, and
11, 10% FBS + 3000 units/ml catalase after 30, 60, and 90 min; lanes 8, 10, and 12, 10% FBS + 20 mM NAC after 30, 60, and 90 min. A time course is shown in
lanes 13-17, representing results after stimulation with
10% FBS for 5, 10, 15, 30, and 60 min, respectively.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 4.
Antioxidants regulate c-Fos production at a
posttranslational level in rat airway smooth muscle. A,
NAC does not affect the rate of c-Fos degradation. Growth-arrested
cells were stimulated with 10% FBS for 60 min. Cells were treated with
NAC (20 mM) or DPBS vehicle, and cycloheximide (25 µg/ml)
was added to medium to block further message translation. Cells were
then harvested 1-6 h later for immunoblot assay of c-Fos. The
immunoblot shown is representative of two experiments: lane
1, 0.5% FBS negative control; lane 2, 10% FBS
positive control harvested after 60 min of stimulation; lanes
3-6, vehicle-treated cells 1, 2, 4, and 6 h after
cycloheximide; lanes 7-10, NAC-treated cells 1, 2, 4, and
6 h after cycloheximide. B, catalase and NAC reduce the
amount of c-fos mRNA in heavy polyribosomal fractions
actively producing protein. Growth-arrested cells were pretreated for
2 h with 3000 units/ml catalase, 20 mM NAC or DPBS,
and stimulated for 30 min with 10% FBS. Cells were then lysed and
centrifuged over linear 15-50% sucrose gradients, and serial 0.6-ml
fractions were collected from the bottom (heaviest to lightest). RNA
from each fraction was dot hybridized onto a nylon membrane and
subjected to Northern analysis with the same c-fos antisense
probe used in Fig. 3. Typical autoradiograms are shown from cells
stimulated with FBS alone (rows A and B) and
cells pretreated with 3000 units/ml catalase (rows C and
D) or 20 mM NAC (rows E and
F). In untreated FBS-stimulated cells, c-fos is
identified in the heaviest polysomal fractions that actively translate
message (A1-4), but in cells pretreated with antioxidants,
c-fos is not found until much lighter ribosomes (C4 for
catalase and E6 for NAC) less likely to be producing protein. Blots are
representative of two experiments each.
|
|
When rat airway smooth muscle monolayers were incubated with
ferricytochrome c, there was a small but reproducibly
significant increase in absorbance over 60 min after stimulation by
FBS, and this increase could be inhibited by addition of SOD to the
medium (Fig. 5A). Calculating
superoxide (O
2) generation as the SOD inhibitable difference
in A550, airway smooth muscle cells generated 4 ± 2 and 21 ± 3 pmol of O
2/min/µg of cell protein before and after
stimulation with 10% FBS, respectively. DPI reduced FBS-stimulated ferricytochrome c reduction by over 60% (Fig.
5B), suggesting that much of the measurable O
2
originates from a flavoprotein-dependent process. We
therefore studied the effect of DPI on rat airway smooth muscle
proliferation. The same concentration of DPI that decreased
serum-induced ferricytochrome c reduction (10 µM) also reduced FBS-stimulated cell proliferation (Fig.
6A) but was not cytotoxic, as
measured by LDH activity in supernatant or trypan blue dye exclusion
(data not shown). DPI treatment of rat airway myocytes also reduced
expression of c-Fos (Fig. 6B). Nitro-L-arginine did not block serum-induced proliferation (Fig.
7), and allopurinol decreased
proliferation to only a minor, albeit statistically significant, degree
(Fig. 7) compared with other antioxidant strategies (Fig. 1). This
mitigates against either nitric oxide synthase or xanthine oxidase as
major flavoprotein-containing enzymatic sources of reactive oxygen
species involved in airway myocyte growth. Taken together, these
results imply that the origin of reactive oxygen species that are
important for mitogen-induced signaling in airways smooth muscle may be
a membrane-localized flavoprotein dependent NADH or NADPH
oxidoreductase.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Cultured rat airway smooth muscle cells
generate O 2 in response to mitogenic stimulation.
A, FBS stimulates an increase in SOD-inhibitable
ferricytochrome c reduction by rat airway smooth muscle
cells. Values represent the change in absorbance at 550 nm
( A550) per well over 60 min in a mean of 16 experiments. Confluent cells grown on 24-well plates were
growth-arrested for 72 h in serum-free DMEM and incubated at
37 °C with 160 µM ferricytochrome c in HBSS
with and without 10% FBS or copper-zinc SOD (300 units/ml).
A550 of each well, blanked to replicate wells
incubated with ferricytochrome c and SOD without FBS, was
measured initially and after 60 min of serum stimulation. O 2
generation, normalized to cell protein, was computed as SOD-inhibitable
ferricytochrome c reduction using EM = 2.1 × 104 M 1 cm 1 (24).
, ferricytochrome c; , ferricytochrome c + FBS; , ferricytochrome c + FBS + SOD. *,
p < 0.05 compared with ferricytochrome c
without FBS; +, p < 0.001 compared with
ferricytochrome c + FBS + SOD. B, O 2
generation in rat airway smooth muscle is
flavoprotein-dependent. Growth-arrested confluent
monolayers on 24-well plates were incubated under similar conditions
with ferricytochrome c in HBSS with and without 10% FBS or
DPI (10 µM), an inhibitor of
flavoprotein-dependent NADH or NADPH oxidoreductases.
Values represent the A550 over 60 min in a
mean of eight experiments. , ferricytochrome c; ,
ferricytochrome c + FBS; , ferricytochrome c + FBS + DPI. *, p < 0.001 compared with ferricytochrome
c without FBS; +, p < 0.001 compared with
ferricytochrome c + FBS + DPI.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 6.
The flavoprotein-dependent enzyme
inhibitor DPI inhibits cell proliferation (A) and
c-Fos expression (B) in rat airway smooth muscle
cells. A, cells were cultured and cell numbers were
quantitated as described in the text and in Fig. 1. Each
column represents mean MTT formazan absorbance in 6 experiments with 50,000 cells/well cultured for 48 h in DMEM and
10% FBS in the presence or absence of DPI (0-10 µM).
Similar results were seen at 24 and 120 h. , 10% FBS; , FBS + 5 µM DPI; , FBS + 10 µM DPI. *,
p < 0.001 compared with 10% FBS alone. B,
growth-arrested cells were pretreated with DPI (25 µM).
After 60 min, cells were lysed, and protein extracts were subjected to
immunoblotting using a specific anti-c-Fos antibody, as described in
the text and in Fig. 2. The immunoblot shown is representative of two
experiments: lane 1, 0.5% FBS; lane 2, 0.5% FBS + DPI; lane 3, 10% FBS; lane 4, 10% FBS + DPI.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 7.
Xanthine oxidase and nitric oxide synthetase
are not sources of reactive oxygen species important in rat airway
smooth muscle proliferation. Cells were cultured and cell numbers
were quantitated as described in the text and in Fig. 1. Each
column represents mean MTT formazan absorbance in six
experiments with 50,000 cells/well cultured for 48 h in DMEM and
10% FBS in the presence or absence of the xanthine oxidase inhibitor
allopurinol (1 mM) or the nitric oxide synthase inhibitor
-nitro-L-arginine (Nitro-L-Arg)
(100 µM). Similar results were seen at 24 h. *,
p < 0.001 compared with 0.5% FBS; +,
p < 0.05 compared with 10% FBS.
|
|
The best studied NADPH oxidoreductase is that responsible for the
respiratory burst in neutrophils, where it exists as a combination of
two membrane proteins, p22 and the flavoprotein bearing gp91, which
together form a complete cytochrome, b558. To determine whether an
analogous enzyme is responsible for O
2 generation by tracheal
myocytes, we compared the growth responses of cultured tracheal smooth
muscle cells from wild-type and gp91phox null mice to 0.5, 2.5, 5.0, and 10% FBS. Fig. 8 shows that
there was no significant difference in serum growth responses of airway smooth muscle from wild-type versus gp91phox
knockout mice. Myocytes from wild-type and gp91phox knockout
mice also generated equivalent amounts of O
2 in response to
stimulation with 10% FBS (19 ± 4 and 19 ± 5 pmol of
O
2/min/µg of cell protein for myocytes from wild-type and
gp91phox knockout mice, respectively). Taken together, these
findings suggest that the source of O
2 from serum
stimulated airway smooth muscle is an oxidoreductase system
distinct from the membrane NADPH oxidoreductase of
phagocytes.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Serum growth responses are similar for airway
smooth muscle from wild-type ( ) and gp91phox knockout ( )
mice. Each column represents mean MTT formazan
absorbance in four experiments, with 50,000 cells/well cultured for
48 h in DMEM and 0.5, 2.5, 5.0, and 10.0% FBS. There was no
significant difference between cell types in growth response to serum.
Similar results were seen at 24 h.
|
|
Using antioxidants clinically to reduce airway smooth muscle
proliferation and adverse airways remodeling in severe asthma is
difficult to envision because of the problem of delivering sufficient
concentrations of NAC or enzymatic agents such as catalase to the
airway wall on a sustained basis. We therefore studied probucol, a
lipophilic lipid lowering agent with even more potent antioxidant
activity than
-tocopherol. As shown in Fig.
9, the dimethyl sulfoxide
(Me2SO) vehicle (0.5% final concentration in medium)
produced a small but significant reduction in airway smooth muscle
proliferation, further supporting a role for reactive oxygen species in
serum-induced mitogenesis. Compared with cells treated with vehicle
alone, probucol at concentrations of 10
5 M
and greater dramatically reduced the growth of airway smooth muscle
cells stimulated with FBS. Similarly, 10
4 M
probucol also significantly reduced cellular proliferation from 75 ng/ml PDGF by over 50% at 48 h (p < 0.001, data
not shown). Therefore, probucol and similar long-lived lipophilic
antioxidants may provide therapeutic approaches for exploiting
antioxidant disruption of mitogenic signaling in the airway smooth
muscle of humans.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 9.
The antioxidant lipid lowering agent probucol
inhibits proliferation of rat airway smooth muscle cells. Cells
were cultured and cell numbers were quantitated as described in the
text and in Fig. 1. Each column represents mean MTT formazan
absorbance in six experiments with 50,000 cells/well cultured for
48 h in DMEM and 10% FBS in the presence or absence of probucol
(10 3-10 6 M) added to media in
5 µl of Me2SO as vehicle. Similar results were seen at
24 h. *, p < 0.05 compared with 10% FBS; +,
p < 0.001 compared with 10% FBS + Me2SO
vehicle.
|
|
 |
DISCUSSION |
Once regarded as merely waste byproducts of aerobic metabolism or
molecules of defense produced by host inflammatory cells against
invading organisms, reactive oxygen species are now understood to be
major mediators of human disease (28). Initially, the involvement of
reactive oxygen species in illness was conceptualized as the chemistry
of "scorched earth," in which critical cell proteins and lipids
were indiscriminately oxidized and rendered metabolically inactive for
their roles in normal cell function (28). More recently, it has been
realized that oxidants can operate as signaling molecules, controlling
even gene expression (1). In the airway, treatment of tracheal myocytes
with exogenous H2O2 has been shown to activate
extracellular extracellular signal-regulated kinases (7) via successive
activation of protein kinase C, Raf-1, and mitogen-activated protein
kinase/extracellular signal-regulated kinase kinase 1 (8). This
provides a scheme by which oxidant stimulation could directly effect
transduction of mitogenic signals to the nucleus. We have extended
these observations by showing that antioxidant treatment of tracheal
myocytes dramatically reduces cell proliferation in response to
mitogenic stimulation with serum or PDGF (Figs. 1 and 9). Antioxidants
also inhibited expression of c-Fos (Fig. 2), the product of an early
response gene subsequently up-regulated by mitogens in response to
cooperative protein kinase C and Ras/Raf stimulation of members of the
mitogen-activated protein kinase superfamily of serine-threonine
kinases. Finally, serum stimulation of airway smooth muscle cells
promoted a small but reproducibly significant increase in O
2
(Fig. 5) release by myocytes into culture medium. Taken together, these
results provide evidence that reactive oxygen species are generated
directly in response to mitogenic stimulation of airway smooth muscle
and that these reactive molecules may be physiologically important in
signaling subsequent events leading to proliferation.
At present, the enzymatic source and chemical identity of the reactive
oxygen to species proximate in signaling are not clear. Previous
studies have suggested evidence for both O
2 (2, 20) and
H2O2 (3, 4, 6, 14, 15) generation in response to mitogenic stimulation of mesangial cell, adipocytes, fibroblasts and
aortic vascular smooth muscle cells. Increased ferricytochrome c reduction (Fig. 5B), serum-induced cell
proliferation (Fig. 6A), and c-Fos expression (Fig.
6B) were prevented by pretreatment of cells with DPI. This
suggests that mitogen-induced reactive oxygen species in airway smooth
muscle cells are from a flavoprotein-dependent source, such as
an NADH or NADPH oxidoreductase, as previously reported for other cell
types (2, 3, 4, 6, 14, 15, 20). Our results (Fig. 1A) and
those of others (6) showing that catalase, but not SOD, prevents
airways smooth muscle proliferation, indicate that the proximate
diffusible oxidant species important for signaling may be
H2O2. The enhancement of PDGF-stimulated cell
proliferation by SOD supports this supposition. Whether NADH or NADPH
is an important electron donor for generation of reactive oxygen
species by airway smooth muscle, whether the oxidase is localized to
the cell membrane or cell interior, and whether
H2O2 is a primary enzymatic product or is in
part formed from dismutation of O
2 spontaneously or by
extracellular SOD, are issues that are currently being investigated.
Knowledge about the structure and function of NADH/NADPH oxidoreductase
comes mostly from studies in neutrophils, where it is responsible for
the respiratory burst essential to the microbiocidal activity of these
cells. The neutrophil oxidase is a multisubunit complex that generates
O
2 in one-electron reduction of O2 using electrons
supplied by NADPH (29). The oxidase is expressed at high levels in
phagocytes, where O
2 is the precursor to
H2O2 and other reactive oxidants that are used
to kill bacteria and fungi. Structurally, the oxidase consists of two
membrane proteins, gp91 and p22, that together form a unique cytochrome
with a redox midpoint potential of
245 mV and a reduced minus
oxidized difference spectrum of 558. The O
2 generating
capacity is fully contained within the cytochrome. Based on studies of
subjects with chronic granulomatous disease, at least two cytosolic
peptides (p47 and p67) are also essential. It is generally believed
that these components have to interact with the membrane-bound
cytochrome to induce oxidase activity. Several other cytosolic
components that appear to participate in the activity of the phagocyte
NADPH oxidase have been identified, and include a small G protein
(rac-1 or rac-2), rho-GDI, and p40phox (30). In neutrophils,
the oxidase is activated by assembly of the cytosolic proteins with the
membrane components. Heritable defects of either gp91, p22, p47, or p67
are the basis for granulomatous disease, a disorder of white cell
function characterized by recurrent severe bacterial and fungal
infections (29). During the past few years, evidence has been
accumulating that a similar enzyme complex is present and exerts a
variety of functions in nonphagocytic cells. Both the endothelium and
vascular smooth muscle contain a membrane-bound oxidase that utilizes
NADH or NADPH as substrates for electron transfer to O2,
which appears similar to the NADPH oxidase of neutrophils (31, 32). In
cultured vascular smooth muscle cells, the oxidase is a significant
source of O
2 formation (33). For example, in calf pulmonary
and coronary artery smooth muscle, this oxidase accounts for the
majority of the O
2 generated (34, 35). Importantly, it
utilizes a cytochrome b558 electron transport system (34). There are,
however, important differences between the vascular oxidase and the
neutrophil oxidase. These include the delayed time course for
activation, low output, and, in some studies, preference for NADH
rather than NADPH of the vascular (34, 35) and fibroblast (4) oxidases.
Recent immunohistochemical studies have suggested expression of gp91 in
vascular smooth muscle cells (32), but this has not been a consistent
finding (36). Because the substrate recognition site, the flavin
adenine dinucleotide binding site, and the heme binding site are all
contained in gp91, it is likely that it is this subunit that determines
the unique properties of the enzyme. Therefore, our finding of similar
serum-induced growth rates (Fig. 8) and O
2 generation for
airway smooth muscle in wild-type and gp91phox null mice would
suggest distinct structural differences between the
O
2-generating oxidases of tracheal myocytes and phagocytic cells.
Although the exact enzymatic source of growth promoting reactive oxygen
species is unclear, a prominent effect of oxidant stimulated
mitogen-activated kinase cascades (8, 9) is the promotion of growth by
rapid induction of early response genes, which include transcription
factors that regulate the expression of other genes that are critical
for cellular proliferation. The induction of c-fos gene
expression is one of the earliest nuclear responses to a wide variety
of growth and differentiation factors (37-39). Products of the
fos gene family now include c-Fos, Fos-B, Fra-1, and Fra-2.
Fos family proteins dimerize with other proteins of the Jun family to
form the transcription factor AP-1, which activates transcription of a
variety of target genes leading to initiation of DNA synthesis and
eventually to mitosis (40, 41). The extent of transcriptional
activation or repression conferred upon AP-1 response elements is a
function of the particular heterodimers that are formed and the cell
type in which they are expressed (40). Fos proteins can also interact
with the c-AMP-responsive element. In fibroblasts, c-Fos and Fos-B
mediate cell cycle progression by acting at c-AMP-responsive elements
in conjunction with cyclic-AMP responsive element protein/cyclic-AMP
responsive element modulator transcription factors to promote cyclin D1
expression (42), and in vascular smooth muscle, c-Fos interacts with a
c-AMP-responsive element in the cyclin A promoter to cooperate with the
transcription factor E2F in the initiation of cyclin A expression (43).
Antisense c-fos RNA inhibits cell proliferation (44) and
reverses phenotypic transformation (45). Microinjection of antibodies
to c-Fos, Fos-B, or Fra-1 alone only partially blocks cell cycle
reentry, but inhibiting all three genes for these proteins together
effectively abolishes cell cycle progression (44). In addition,
combined c-fos
/
,
fosB
/
mice are approximately 50-60%
smaller at 6 weeks than wild-type mice, and their fibroblasts have
dramatically reduced proliferation that is at least in part from a
failure to induce cyclin D1 following serum-stimulated cell cycle
reentry (46). Thus, fos gene family products as a whole are
pivotally important for cell growth.
There is evidence that fos may play a similarly significant
role in airway wall remodeling. Mitogenesis of airway smooth muscle is
also associated with early c-fos expression (47-50), and
levels of c-Fos are increased in biopsies of asthmatic airways (51, 52). Serum stimulation strongly increased both expression of c-Fos
protein and proliferation of airway smooth muscle cells, and both of
these events were significantly inhibited by antioxidants. However,
despite the previously demonstrated importance of c-Fos in mitogenesis,
additional studies will be needed to demonstrate that
antioxidant-mediated reductions in c-Fos protein expression and airway
smooth muscle proliferation are functionally related. Expression of
fos products may also be important in the kinetics of matrix
deposition within the remodeling airway wall. Fibroblasts from
c-fos
/
mice suffer impaired
AP-1-dependent basal and mitogen-stimulated expression of
matrix metalloproteinases, including stromelysin and collagenase (53).
In the vessel wall, migration of smooth muscle cells into areas of
active remodeling is critically dependent upon the activity of
metalloproteinases needed to digest away obstructing extracellular
matrix proteins (54). Although not yet studied in the airway, matrix
metalloproteinases may perform similar functions to allow airway
myocytes to migrate into sites of active remodeling.
In other cells, activation of c-fos by
H2O2 (55) or hormones such as angiotensin II
that stimulate cellular H2O2 production (56) is
regulated by both transiently enhanced transcription and stabilization
of mRNA. In the present investigation, serum treatment increased
c-fos mRNA levels in airway smooth muscle, and
antioxidants did not affect this response (Fig. 3). However, antioxidant treatment markedly reduced levels of c-Fos protein (Fig.
2), suggesting interruption at a posttranscriptional level. Protein
half-life appeared substantially unchanged by antioxidant treatment
(Fig. 4A), but catalase and NAC reduced incorporation of
c-fos mRNA into heavier polyribosomes associated with
endoplasmic reticulum (Fig. 4B), in which message is
actively translated. This would suggest the existence of a novel
redox-sensitive trans-acting mechanism regulating ribosomal
translation of c-fos mRNA. Antioxidants have been
previously shown to inhibit posttranscriptional expression of
macrophage tissue factor (57), and redox-sensitive RNA-binding proteins
have been reported to regulate translation of catalase (58), manganese
superoxide dismutase (59), erythropoietin (60), thymidylate synthase
(61), c-Myc (61), and p53 (61) mRNAs. One potential explanation for
redox regulation of c-fos translation would be through an
RNA-binding protein similar to iron-responsive element-binding protein
1, with suppression of c-fos translation when the binding
protein is attached, but unfettered translation with detachment of the
binding protein from message. The RNA binding activity of
iron-responsive element-binding proteins is regulated in part at
cysteine 437, the oxidation of which reduces iron-responsive
element-binding protein 1 binding to the 5'-untranslated region of
ferritin mRNA, releasing it from translational blockade (62). The
5'-untranslated region of rat c-fos contains two
iron-responsive element loop sequences, CAGUGN (where N is any
nucleotide other than G) (62), at bases 45-50 and 87-91, but these
are not flanked by complementary bases necessary for stem formation
(63). Nevertheless, a similar c-fos-binding protein
redox-regulated at a cysteine critical for binding would be compatible
with facilitation of ribosomal translation during the prooxidant stress
of serum stimulation and inhibition by a reducing environment.
Whereas others have studied airway smooth muscle proliferation in
response to individual mitogens, such as histamine (47), endothelin
(49), or PDGF (64, 65), we have previously found that endothelin,
histamine, and PDGF individually are weak stimuli for cellular
proliferation compared with FBS (18). Fetal serum contains a complex
mixture of mitogens more reflective of the complex environment to which
asthmatic airway smooth muscle is exposed in vivo. The
interactions of various mitogens on cellular oxidant generation may be
complicated. In fibroblasts, insulin, insulin-like growth factor-1,
acidic fibroblast growth factor, and the AA homodimer of PDGF all
stimulated NADPH-dependent generation of
H2O2, whereas the basic isoform of fibroblast
growth factor and the BB homodimer of PDGF antagonized it (66). Also,
as a consequence of submucosal edema and increased submucosal vascular permeability, the asthmatic airway normally contains elevated levels of
many serum components (10-13). We therefore chose to perform most of
our experiments with serum as the mitogenic stimulus.
Previously, asthma was defined as episodic reversible airways
obstruction, but it is now appreciated that patients with chronic severe asthma can suffer irreversible obstruction of airways (67, 68).
This complication develops from architectural remodeling of the airway
wall, resulting in increased smooth muscle mass (67) from both
hyperplasia and hypertrophy (69), as well as remodeling of other
elements. Airway smooth wall remodeling occurs more often in older
asthmatics (67, 68), is often clinically refractory to current
bronchodilator and anti-inflammatory therapies, including
glucocorticoids (67, 68), and may contribute significantly to the
nonspecific bronchial hyperresponsiveness characteristic of asthma
(70). Formulation of an effective therapy for this process could
represent an important advancement in the treatment of chronic severe asthma.
Probucol treatment dramatically reduced proliferation of airway smooth
muscle in response to serum stimulation (Fig. 9). Probucol has been
previously shown to blunt the mitogenic effect of
H2O2 for vascular smooth muscle (71) and has
recently been demonstrated to prevent vessel restenosis after
transluminal angioplasty in humans (72). Long used as a lipid lowering
agent, probucol is a potent antioxidant that reduces oxidative
modification of low density lipoprotein in vivo (20) and
inhibits lipopolysaccharide-induced interleukin-1 secretion by
macrophages (73). Steady-state blood levels of probucol in humans
(5 × 10
5 M) (74) are well above the
minimally significant concentration of probucol (1 × 10
5 M) required for inhibition of airway
smooth muscle proliferation in vitro (Fig. 9). At present,
there is no known effective prevention or treatment for airway wall
remodeling. If additional studies confirm the role of reactive oxygen
species as physiologically important signaling molecules in the
proliferation of airway myocytes, probucol and its analogs or similar
antioxidants might offer practical potential as therapies to prevent or
treat airway wall remodeling in humans.
 |
ACKNOWLEDGEMENT |
We gratefully acknowledge the technical
assistance of Dr. Francois Villinger (Department of Pathology, Winship
Cancer Center, Emory University, Atlanta, GA).
 |
FOOTNOTES |
*
This work was supported by the Carolinas Medical Center
Health Services Foundation (to T. P. K.) and in part by funds from the ALA Asthma Research Center at the University of Utah and HL40665 (to J. R. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: P.O. Box 32861, Dept.
of Internal Medicine, Carolinas Medical Center, Charlotte, NC 28232. Tel.: 704-355-7851; Fax: 704-355-7648.
 |
ABBREVIATIONS |
The abbreviations used are:
DMEM, Dulbecco's
modified Eagle's medium;
HBSS, Hanks' balanced salt solution, FBS,
fetal bovine serum;
PDGF, platelet-derived growth factor;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;
PBS, phosphate buffered saline;
DPBS, Dulbecco's PBS;
Me2SO, dimethyl sulfoxide;
NAC, N-acetylcysteine;
DPI, diphenyleneiodonium;
SOD, superoxide dismutase;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
RT, reverse transcription;
PCR, polymerase chain reaction.
 |
REFERENCES |
| 1.
|
Winyard, P. G.,
and Blake, D. R.
(1997)
Adv. Pharmacol.
38,
403-421
|
| 2.
|
Satriano, J. A.,
Shuldiner, M.,
Hora, K.,
Xing, Y.,
Shan, Z.,
and Schlondorff, D.
(1993)
J. Clin. Invest.
92,
1564-1571
|
| 3.
|
Thannickal, V. J.,
Hassoun, P. M.,
White, A. C.,
and Fanburg, B. L.
(1993)
Am. J. Physiol.
265,
L622-L626[Abstract/Free Full Text]
|
| 4.
|
Thannickal, V. J.,
and Fanburg, B. J.
(1995)
J. Biol. Chem.
270,
30334-30338[Abstract/Free Full Text]
|
| 5.
|
Feng, L.,
Xia, Y.,
Garcia, G. E.,
Hwang, D.,
and Wilson, C. B.
(1995)
J. Clin. Invest.
95,
1669-1675
|
| 6.
|
Irani, K.,
Xia, Y.,
Zweier, J. L.,
Sollott, S. J.,
Der, C. J.,
Fearon, E. R.,
Sundaresan, M.,
Finkel, T.,
and Goldschmidt-Clermont, P. J.
(1997)
Science
275,
1649-1652[Abstract/Free Full Text]
|
| 7.
|
Abe, M. K.,
Chao, T.-S. O.,
Solway, J.,
Rosner, M. R.,
and Hershenson, M. B.
(1994)
Am. J. Respir. Cell Mol. Biol.
11,
577-585[Abstract]
|
| 8.
|
Abe, M. K.,
Kartha, S.,
Karpova, A. Y.,
Li, J.,
Liu, P. T.,
Kuo, W.-L.,
and Hershenson, M. B.
(1998)
Am. J. Respir. Cell Mol. Biol.
18,
562-569[Abstract/Free Full Text]
|
| 9.
|
Radeke, H. H.,
Cross, A. R.,
Hancock, J. T.,
Jones, O. T. G.,
Nakamura, M.,
Kaever, V.,
and Resch, K.
(1991)
J. Biol. Chem.
266,
21025-21029[Abstract/Free Full Text]
|
| 10.
|
Persson, C. G. A.
(1986)
Lancet
2,
1126-1128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Boucher, R. C.,
Pare, P. D.,
and Hogg, J. C.
(1979)
J. Allergy Clin. Immunol.
64,
197-201 |